Clinical Trials Directory

Trials / Completed

CompletedNCT02912065

Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay

Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay: A Retrospective Assessment

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
13 Months – 17 Years
Healthy volunteers
Not accepted

Summary

A retrospective chart review to assess feeding tolerance in children who had been switched from an intact protein formula to a Peptide based formula due to feeding intolerance in a pediatric facility for the developmentally delayed.

Detailed description

Medical records of pediatric patients with enteral feeding intolerance on standard polymeric formulas that were switched to a peptide based formula will be retrospectively analyzed. Data will be collected on caloric intake, ability to meet enteral nutrition goals, incidence of intolerance, and the use of medications to control gastrointestinal symptoms.

Conditions

Timeline

Start date
2015-01-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2016-09-23
Last updated
2016-10-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02912065. Inclusion in this directory is not an endorsement.

Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay (NCT02912065) · Clinical Trials Directory